Nicofuranose
From Wikipedia, the free encyclopedia
Nicofuranose
|
|
Systematic (IUPAC) name | |
[(2R,3S,4R,5R)-2-hydroxy-4-(pyridine-3-carbonyloxy)-2,5-bis(pyridine-3-carbonyloxymethyl)oxolan-3-yl] pyridine-3-carboxylate | |
Identifiers | |
CAS number | ? |
ATC code | C10 |
PubChem | |
Chemical data | |
Formula | C30H24N4O10 |
Mol. mass | 600.533 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Nicofuranose is a niacin derivative used as a hypolipidemic agent.
|